[HTML][HTML] Post COVID-19 irritable bowel syndrome

G Marasco, C Cremon, MR Barbaro, G Cacciari… - Gut, 2023 - gut.bmj.com
… For this study, hospitalised patients with or without COVID-19 … Third, we included a control
group of hospitalised patients for … at baseline compared with patients with COVID-19, thus …

Ethnicity and outcomes in patients hospitalised with COVID-19 infection in East London: an observational cohort study

VJ Apea, YI Wan, R Dhairyawan, ZA Puthucheary… - BMJ open, 2021 - bmjopen.bmj.com
… We report on treatment and outcomes in COVID-19 patients hospitalised in East London …
highest COVID-19 mortality. To our knowledge, this is one of the largest UK hospital COVID-19

[PDF][PDF] Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020

SB Israelsen, KT Kristiansen, B Hindsberger… - Dan Med …, 2020 - content.ugeskriftet.dk
… and laboratory findings for each patient category. This report contributes to the knowledge
of COVID-19 in hospitalised patients in Denmark, which at current is limited to a report on 16 …

Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID19 diagnosis

B Tholin, W Ghanima, G Einvik, B Aarli… - British Journal of …, 2021 - Wiley Online Library
COVID-19 is uncertain. Here we present data on the incidence of VTE in both hospitalised
and non-hospitalised patients … The incidence of VTE after diagnosis of COVID-19 was 3·9% [95…

COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

CG Rodriguez-Gonzalez, E Chamorro-de-Vega… - International journal of …, 2021 - Elsevier
… with the first 1255 cases receiving anti-COVID-19 treatment at a Spanish hospital. … a cohort
of over 1200 patients with COVID-19 who were admitted to a public hospital in the Community …

[HTML][HTML] Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis

MT Angamo, MA Mohammed, GM Peterson - Infection, 2022 - Springer
… a total of 3686 patients hospitalised with moderate-to-severe COVID-19 and compared
the … included hospitalised patients aged 12 years or over with moderate-to-severe COVID19

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

L Catteau, N Dauby, M Montourcy, E Bottieau… - International journal of …, 2020 - Elsevier
… for hospitalised patients with COVID-19. We conducted a retrospective analysis of in-hospital
mortality in the Belgian national COVID-19 hospital surveillance data. Patients treated …

Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
… clinical phases of COVID-19, particularly in patients with moderate to severe COVID-19, the
… be effective in the treatment of hospitalised patients with COVID-19. This study involved 500 …

Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute …

M Scarsi, S Piantoni, E Colombo, P Airó… - Annals of the …, 2020 - ard.bmj.com
patients with COVID-19 pneumonia and the anti-inflammatory properties of colchicine,
we postulated the rationale of use of colchicine in patients admitted to the hospital for COVID-19. …

The role of antirheumatics in patients with COVID-19

CB Nissen, S Sciascia, D de Andrade… - The Lancet …, 2021 - thelancet.com
… in which patients who were in hospital with COVID-19 were randomly assigned to receive
6 mg dexamethasone daily (n=2104) or standard of care (n=4321). 28-day mortality rate was …